Select your office

Smart Cities – Turning challenge into opportunity

The 100 largest cities in the world produce 25% of the planet’s wealth. To succeed more and more cities are going “Smart” in order to meet their biggest challenges and enrich the quality of their citizens’ lives. This unstoppable trend is driving double-digit growth in a trillion-dollar global...

Digital Pharma - Responding to Challenges and Opportunities...

Innovation has always been one of the foundations for success in the pharmaceutical industry.

Healthcare & life sciences Digital company transformation

Innovation in the healthcare space

The business model of the pharmaceutical industry is changing fast: The era of blockbuster medications with big margins is over. Instead, patient-centric medication is the way forward.

Healthcare & life sciences Technology & innovation management

The birth of Neo-Petronationalism: a new emerging model

In 2013 Mexico approved an ambitious energy reform that ended 70 years of Petronationalism. The country opened its market and now allows private and international investors to participate through a range of contracting models.

Oil & gas

Opportunities and challenges for Global Deepwater Players

The pace of deepwater drilling has increased by 40 % over the last three years. While technology is a key enabler for deepwater development, players still face many critical challenges and decisions which require close attention if projects are to be delivered successfully.

Oil & gas

Opportunities and challenges for energy players in the...

Fracking technology has recently enabled the large-scale exploitation of vast amounts of shale gas and oil, impacting energy equations and balances across the world.

Oil & gas

“Mastering the complexity of a growing global footprint”

The real globalization of our footprint started in 1995, when the company was privatized and acquired by the Benetton family. This brought a new wave of enthusiasm and ambition.

How business leaders can care about the world – profitably

In today’s world the question of third-party interests is of increasing importance as companies leave their footprint around the globe in different societies. How and to what degree should executives allow for these externalities?

Putting patients at the center of a new biopharma business...

The pharmaceutical industry is suffering. Expiring patents, increasing demands from regulators and decreasing healthcare budgets are putting companies under pressure, and the industry has to walk a narrow tightrope between keeping profitability up and quickly developing attractive medications....

“The future is about cooperative competition”

Mr Bajaj, in the long term some people foresee the business world evolving into a bipolar one: the “West” versus the “Emerging Markets.” Would you concur with that view?